N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Olivia Dean; Frank Giorlando; Michael Berk

doi:10.1503/jpn.100057

Review Paper

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Olivia Dean, Frank Giorlando and Michael Berk

J Psychiatry Neurosci March 01, 2011 36 (2) 78-86; DOI: https://doi.org/10.1503/jpn.100057

Olivia Dean

Dean, Berk — Mental Health Research Institute, Parkville; Dean, Giorlando, Berk — Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong; Berk — Youth Health Orygen Research Centre, Parkville, and the School of Medicine, Faculty of Health, Medicine, Nursing and Behavioural Sciences, Deakin University, Geelong, Victoria, Australia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: [email protected]

Frank Giorlando

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Berk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Tables
Responses
Metrics
PDF

Submit a Response to This Article

Compose Response

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

References

References

Author Information

Contributors

First Name and Middle Initial *

First or given name, e.g. 'Peter'.

Last Name *

Your last, or family, name, e.g. 'MacMoody'.

Degrees

Email Address *

Your email address, e.g. [email protected]

Occupation *

Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.

Affiliation *

Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.

Address

Your organization, institution's or residential address.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No Responses have been published for this article.

PreviousNext

In this issue

Journal of Psychiatry and Neuroscience: 36 (2)

J Psychiatry Neurosci

Vol. 36, Issue 2

1 Mar 2011

Table of Contents
Index by author

Article tools

Respond to this article

Download PDF

Article Alerts

User Name *

Password *

To sign up for email alerts or to access your current email alerts, enter your email address below:

Email *

Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Message Subject (Your Name) has sent you a message from JPN

Message Body (Your Name) thought you would like to see the JPN web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Olivia Dean, Frank Giorlando, Michael Berk

J Psychiatry Neurosci Mar 2011, 36 (2) 78-86; DOI: 10.1503/jpn.100057

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Olivia Dean, Frank Giorlando, Michael Berk

J Psychiatry Neurosci Mar 2011, 36 (2) 78-86; DOI: 10.1503/jpn.100057

Share This Article:

Tweet Widget
Facebook Like

No related articles found.

PubMed
Google Scholar

Cited By...

NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos
Vitamin D and Depression: Cellular and Regulatory Mechanisms
Acetylcysteine for treatment of autism spectrum disorder symptoms
Oral acetylcysteine for neuropsychiatric disorders
N-Acetylcysteine- and MK-801-Induced Changes in Glutamate Levels Do Not Affect In Vivo Binding of Metabotropic Glutamate 5 Receptor Radioligand 11C-ABP688 in Rat Brain

Google Scholar

Main menu

User menu

Search

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Plain text

Vertical Tabs

Jump to comment:

In this issue

Article tools

Citation Manager Formats

Related Articles

Cited By...

Similar Articles

Content

Authors & Reviewers

About